QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference
QuidelOrtho (QDEL), a global provider of in-vitro diagnostic technologies, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team will deliver a presentation on Monday, January 13, 2025, at 7:30 a.m. PST / 10:30 a.m. EST. Investors and interested parties can access both the live webcast and replay through the 'Events & Presentations' section on QuidelOrtho's investor relations website.
QuidelOrtho (QDEL), fornitore globale di tecnologie diagnostiche in vitro, ha annunciato la sua partecipazione al 43° Congresso Annuale J.P. Morgan Healthcare. Il team di gestione dell'azienda terrà una presentazione lunedì 13 gennaio 2025, alle 7:30 PST / 10:30 EST. Gli investitori e le parti interessate possono accedere sia alla diretta streaming che alla registrazione nella sezione 'Eventi e Presentazioni' del sito web delle relazioni con gli investitori di QuidelOrtho.
QuidelOrtho (QDEL), proveedor global de tecnologías de diagnóstico in vitro, ha anunciado su participación en la 43ª Conferencia Anual del J.P. Morgan Healthcare. El equipo directivo de la compañía realizará una presentación el lunes 13 de enero de 2025, a las 7:30 a.m. PST / 10:30 a.m. EST. Los inversores y partes interesadas pueden acceder tanto a la transmisión en vivo como a la repetición a través de la sección 'Eventos y Presentaciones' en el sitio web de relaciones con inversores de QuidelOrtho.
QuidelOrtho (QDEL), 인체 외 진단 기술의 글로벌 제공업체,는 제43회 J.P. Morgan Healthcare 컨퍼런스에 참여한다고 발표했습니다. 회사의 경영진이 2025년 1월 13일 월요일, 오전 7:30 PST / 오전 10:30 EST에 발표를 진행할 예정입니다. 투자자와 이해관계자는 QuidelOrtho의 투자자 관계 웹사이트의 '이벤트 및 발표' 섹션을 통해 라이브 웹캐스트와 재생 영상을 모두 이용할 수 있습니다.
QuidelOrtho (QDEL), fournisseur mondial de technologies de diagnostic in vitro, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. L'équipe de direction de l'entreprise fera une présentation le lundi 13 janvier 2025, à 7h30 PST / 10h30 EST. Les investisseurs et les parties intéressées peuvent accéder à la diffusion en direct et à la rediffusion dans la section 'Événements et Présentations' du site Web des relations avec les investisseurs de QuidelOrtho.
QuidelOrtho (QDEL), ein globaler Anbieter von In-vitro-Diagnosetechnologien, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz angekündigt. Das Management-Team des Unternehmens wird am Montag, den 13. Januar 2025, um 7:30 Uhr PST / 10:30 Uhr EST eine Präsentation halten. Investoren und interessierte Parteien können sowohl auf die Live-Übertragung als auch auf die Aufzeichnung im Abschnitt 'Veranstaltungen und Präsentationen' auf der Investor-Relations-Website von QuidelOrtho zugreifen.
- None.
- None.
The Company’s presentation is scheduled for Monday, January 13, 2025 at 7:30 a.m. PST / 10:30 a.m. EST.
Interested parties can access the live webcast and replay in the “Events & Presentations” section of the “Investor Relations” page of QuidelOrtho’s website at https://ir.quidelortho.com/.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in-vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence.
Building upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects and a more informed path is illuminated for each of us.
QuidelOrtho is advancing diagnostics to power a healthier future.
For more information, please visit www.quidelortho.com.
Source: QuidelOrtho Corporation
View source version on businesswire.com: https://www.businesswire.com/news/home/20241230050271/en/
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@QuidelOrtho.com
Source: QuidelOrtho Corporation
FAQ
When is QuidelOrtho (QDEL) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch QuidelOrtho's (QDEL) J.P. Morgan Healthcare Conference presentation?
Which healthcare conference is QuidelOrtho (QDEL) participating in January 2025?